This website contains forward-looking statements. These statements may be identified by words such as “expect,” “should,” “could,” “shall,” and similar expressions. We caution that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which we operate; behavior of customers, suppliers, and competitors; technological developments; and legal, tax, and regulatory rules affecting our businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as penny stock rules, currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Metatron disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
- Metatron, Inc. has introduced Series B Preferred Shares.
- Metatron ($MRNJ) Lights Up 4/20 With Marijuana App Release
- ($MRNJ) Metatron Social Media Stats Way Up on Cannabis App News
- ($MRNJ) Metatron Announces Its Cannabis Medical App Development
- ($MRNJ) Metatron to Acquire Marijuana Technology Leader Buzzlink
- ($MRNJ) Metatron to Develop BajaVino Wine Club Subscription App
- $MRNJ Adds Cannabis Subsidiary
- ($MRNJ) Metatron App Sales up 71% week over week, Social Media Stats Up, Marijuana App Revamp
- Metatron plans To Release Revamped Canniboids App This 4/20
- Metatron (OTC MRNJ) Announces $1,000,000 Reg A Capital Raise to fund Cannabis & Vaporize a Secure Chat App(s)
160 Greentree Drive, Suite 101
Dover, DE 19904